Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-939-3 | CAS number: 7378-99-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03 January 1996 - 13 September 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- not specified
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Dimethyl(octyl)amine
- EC Number:
- 230-939-3
- EC Name:
- Dimethyl(octyl)amine
- Cas Number:
- 7378-99-6
- Molecular formula:
- C10H23N
- IUPAC Name:
- dimethyl(octyl)amine
- Details on test material:
- Name: AD 1
Chemical Name: N, N-Dimethyloctylamine
CAS No.: 7378-99-6
Batch No.: 13602808
Expiry Date: not applicable
Physical State at Room Temperature: liquid
Colour: clear
Volatility: volatile
Density: 0.765
Molecular Weight: 157.3
Active Components: > 95%
Structure Formula of
Active Component: C8H17-N-(CH3)2
Storage Conditions: at room temperature
Constituent 1
- Specific details on test material used for the study:
- The test material was prepared at appropriate concentrations in maize oil to permit administration at a constant volume-dosage of 10 ml/kg bodyweight
Dosages were calculated and expressed gravimetrically in terms of the material as received. Fresh formulations of the test material were prepared on the morning of administration and any surplus remaining after dosing was disposed of on the same day.
No analyses were undertaken to assess the stability, homogeneity or achieved concentrations of the test material in the vehicle.
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The animals were housed in stainless steel grid cages (RS Biotech, Northants, England). The grid floor ensured rapid removal of waste material to undertrays which were cleaned as necessary. Five animals of the same sex were accommodated in each cage, unless reduced by mortality. The cages were suspended in mobile stainless steel racks.
The animals were held in a limited-access facility. All rooms were kept at slight positive pressure relative to the outside and each had its own filtered air supply giving at least 10 complete air changes per hour without re-circulation. Target values for temperature and humidity were 21°C (range 19°-25°C) and 55% R.H (range 40%-70% R.H.), respectively. The achieved values were monitored daily. Electric time-switches regulated a lighting cycle of 12 hours of artificial light per day. An emergency generator was available to maintain the electricity supply in the event of a power failure. All personnel entering the building changed into clean protective clothing and wore an oversuit, gloves, plastic over-shoes and face mask to service animal holding areas. A commercially-available complete pelleted rodent diet (RMl(E) SQC, from Special Diets Services Limited, Witham, Essex, England) was fed ad libitum. The manufacturer supplied analytical data with each batch of diet which included concentrations of nutritional components, aflatoxins and selected
heavy metals, pesticides and micro-organisms. The diet contained no added antibiotic or other chemotherapeutic or prophylactic treatment. Samples of diet were taken for analysis at six-monthly intervals to detect potential contaminants by a laboratory independent of the supplier. Results of these analyses are retained in the archives.
Animals had free access to tap water taken from the public supply; in England the supply and quality of this water is governed by Department of the Environment regulations. Certificates of analysis were routinely received from the supplier (Essex and Suffolk Water pie). At approximately six-month
intervals water was routinely sampled for analysis, by a laboratory independent of the supplier, for selected chlorinated and organophosphorus pesticides, polychlorinated biphenyls and lead and cadmium contaminants; it was also examined for coliform bacteria. Results of these analyses are retained in the archives.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- maize oil
- Details on oral exposure:
- A preliminary study was carried out using two groups of one male and one female rat given an oral administration of AP-1 at dosages of 500 and 2000 mg/kg, at a constant volume-dosage of 10 ml/kg in maize oil.
Dose-volume was determined for each animal according to the fasted bodyweight on the morning of dosing. The dose was administered on Day 1 at a constant volume-dosage of 10 ml/kg bodyweight.
A flexible catheter was passed down the oesophagus allowing instillation of the dose into the lumen of the stomach. Each animal was returned to its cage and food hoppers were re-filled approximately three hours after dosing. - Doses:
- the main study was carried out using a single group of five male and five female rats given an oral administration of AP-1 at the dosage of 50 mg/kg, at a constant volume dosage of 10 ml/kg in maize oil. Since no animal died a further group of five male and five female rats were treated at 500 mg/kg.
- No. of animals per sex per dose:
- 5 animals per sex per dose
- Control animals:
- no
- Details on study design:
- Three separate recordings of signs were made during the first hour after dosing and two further recordings during the remainder of Day I. From Day 2 onwards, the animals were inspected twice daily and recordings were made once daily. The circumstances of any death were recorded. Any animal showing severe or enduring signs of pain or distress was humanely killed. The bodyweight of each animal was recorded on the day before dosing and on Days I, 8 and 15. The test was terminated on the morning of Day 15.
Results and discussion
- Preliminary study:
- A preliminary study was carried out using two groups of one male and one female rat given an oral administration of AD-1 at dosages of 500 and 2000 mg/kg, at a constant volume-dosage of 10 ml/kg in maize oil.
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- approximate LD50
- Effect level:
- ca. 162 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Slope - 80 degrees
- Key result
- Sex:
- male
- Dose descriptor:
- approximate LD50
- Effect level:
- ca. 382 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Slope - 72 degrees
- Key result
- Sex:
- male/female
- Dose descriptor:
- approximate LD50
- Effect level:
- ca. 342 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Slope - 73°
- Mortality:
- Four male and five female animals treated at 500 mg/kg died on the day of dosing. There was no death amongst the animals treated at 50 mg/kg.
- Clinical signs:
- other: Ante mortem signs were restricted to prone posture in one female animal. The surviving animal treated at 500 mg/kg showed underactivity, staggering gait, hunched posture and piloerection; it was overtly normal after the first over night period. There was
- Gross pathology:
- Necropsy of the decedents revealed areas of fur staining and cases of distension of the small intestine by a yellow viscous fluid. There was no macroscopic abnormality detected amongst the surviving animals.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The test article, when administered by gavage, oral to male albino rats, has an estimated acute oral LD50 of 382 mg/kg bw with a slope of 72°.
The test article, when administered by gavage, oral to female albino rats, has an estimated acute oral LD50 of 162 mg/kg bw with a slope of 80°.
162 mg/kg bw is used for catergorising under GHS. - Executive summary:
The acute oral toxicity of AD-1 was investigated in two groups of five male and five female CD rats. The animals were starved overnight prior to dosing. The test material was administered at dosages of 50 and 500 mg/kg, at a constant volume-dosage of 10 ml/kg in maize oil. Mortality and signs of reaction to treatment were recorded during a subsequent 14-day observation period; the surviving animals were killed on the following day. All animals were subjected to necropsy.
The mortality distribution was as 4/5 males and 5/5 at 500 mg/kg bw. No mortality at 50 mg/kg bw. The deaths occurred on on the day of dosing.
Ante mortem signs comprised prone position. Signs of reaction in the surviving animal treated at 500 mg/kg comprised underactivity, staggering gait, hunched posture and piloerection. There was no sign of reaction to treatment amongst the animals treated at 50 mg/kg.
All surviving animals achieved anticipated bodyweight gains.
Necropsy findings for the decedents were unremarkable. There was no macroscopic abnormality evident amongst animals treated at 50 mg/kg.
Under the conditions of this study the acute oral median lethal dosage (LD50), of the test material was approximately 162 mg/kg in female animals.
Accordingly, AD-1 was assigned to Catergory 3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.